Testing for drug use and disease in humans could soon be much simpler, thanks to new Swedish research.
Whereas drug tests currently rely on blood or urine samples, researchers from the University of Gothenburg have identified a method for drug testing by analysing various compounds in exhaled breath.
Reporting their results today in the Journal of Breath Research, they demonstrate how collecting and analysing externally-produced compounds in the lining fluid of the airways allows for non-invasive testing and monitoring.
Lead author Dr Göran Ljungkvist said: “Exhaled breath contains particles carrying non-volatile substances. The main components, lipids and proteins, are derived from the respiratory tract lining fluid. The collection procedure is non-invasive, can be repeated within a short time span and is convenient. The small mass sampled is, however, an analytical challenge. Nevertheless, exhaled particles are a new and promising matrix for the analysis of biomarkers.
“We took breath samples from 13 subjects who were undergoing methadone management, to explore whether traces of the drug could be detected via their breath, rather than using invasive techniques that disturb the integrity of the subject.
“We also wanted to discover the best method for collecting methadone particles in the exhaled breath, so our study compared two different sampling methods – electret filtration, and impaction.”
The electret filtration method potentially collected exhaled particles of all sizes, while the one based on impaction collected particles in the size range of 0.5 to 7?m, known to reflect respiratory tract lining fluid from the small airways.
The researchers used liquid chromatography-mass spectrometry to analyse the collected samples, as well as investigating the impact of different breathing patterns.
Their results showed methadone was present in all samples using both methods, but when using the method based on impaction, the concentration of methadone in exhaled breath was less than one per cent of the concentration collected by the method based on filtration.
Dr Ljungkvist said: “The difference in collected amounts of methadone between the two methods was, however, huge. That raised secondary questions on the origin of the collected particles, possible contamination from oral fluid, the breathing pattern and finally the design of the collection device.
“The design of the device is crucial in many ways and it is likely that the huge difference in collected amounts is explained by the sampling of different particle size distributions. The device based on filtration also collects larger particles not collected by the method based on impaction. The design also influences the risk of contamination from oral fluid and losses of particles on their way to the actual collecting medium.
“However, we believe the very high amount of methadone collected by the filtration method is probably due to a considerable contribution of methadone from the central airways or oropharyngeal tract.
“Our results, and methods, could have implications for the analysis of endogenous and exogeneous compounds in the exhaled breath as biomarkers of systemic and lung diseases, as well as in development of new approaches to study human exposure to airborne contamination.”
Learn more: Breath test could be possible for drugs and disease
The Latest on: Breath analysis
[google_news title=”” keyword=”breath analysis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Intel stock: don’t hold your breath for a swift recoveryon April 26, 2024 at 8:07 am
Intel Corp (NASDAQ: INTC) is down well over 35% versus its year-to-date high but a Goldman Sachs analyst still doesn’t see it as a bargain. Intel stock has limited upside from here Toshiya Hari ...
- French government holds its breath ahead of credit rating updateson April 26, 2024 at 5:45 am
Moody's and Fitch will issue opinions on France's credit rating. President Macron's government fears a reprimand from the rating agencies, which could have political consequences.
- Owlstone secures $6.5M for breath-based diagnostics for infectious diseaseon April 26, 2024 at 5:40 am
Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic ...
- Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Diseaseon April 25, 2024 at 4:20 am
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda ...
- EUR/USD: The 1.0600 level a breath from collapseon April 16, 2024 at 12:50 am
The single European currency is on the edge of the 1,06 level on the morning hours of Tuesday as geopolitical concerns and the hot inflation announced in the United States last week remain in the ...
- Gold Nanoparticle Sensors for Detecting Chronic Kidney Disease and Disease Progressionon April 15, 2024 at 5:00 pm
CKD-specific breath patterns were obtained from the collective response of the GNP sensors by applying SVM analysis. SVM was also used as a heuristic to select the most relevant GNP sensors out of ...
- Could breath analysis help with gut issues?on April 15, 2024 at 2:07 am
Through OMED Health, Owlstone can supply breath tests for SIBO and food intolerances to people across the UK for just £250. This service includes guidance from an associated consultant specialist who ...
- What disease areas can benefit from breath analysis?on April 14, 2024 at 9:54 pm
This article covers three major case studies (cancer, liver disease, and microbiome) where breath biomarker analysis has been used, and where breath has considerable potential to transform ...
- Air India suspends pilot for 3 months after failing pre-flight breath analyser teston April 9, 2024 at 5:01 pm
Air India has taken action against a female pilot by suspending her for a duration of three months after she failed the pre-flight breath analyser test, as confirmed by an official.
- Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directorson April 2, 2024 at 1:45 am
Dr. Olla is one of only a handful of scientists globally who has ever conducted delta-9 THC analysis in blood and breath. Dr. Olla is an associate professor at University of Detroit Mercy in ...
via Google News and Bing News